Gut microbiota signatures with potential clinical usefulness in colorectal and non-small cell lung cancers.
Application of bacterial metagenomic analysis as biomarkers for cancer detection. The aim of the study was to discover gut microbiota signatures with potential utility in the diagnosis of colorectal cancer (CRC) and non-small cell lung cancer (NSCLC). A prospective study performed on a total of 77 fecal samples from CRC and NSCLC patients and Controls. DNA from stool was driven for bacterial genomic sequencing using the Ion Torrent technology.